Composition:
Contains per ml:
Lincomycin (as hydrochloride) …………………………………………………………. 200 mg
Solvents ad ………………………………………………………………………………… 1 ml
Description:
Lincomycin Injection contains lincomycin hydrochloride, an antibiotic produced by Streptomyces lincolnensis var. Lincolnensis, which is chemically distinct from all other clinically available antibiotics and is isolated as a white crystalline solid.
Indications:
Lincomycin Injection is indicated for the treatment of infectious forms of arthritis caused by organisms sensitive to its activity. This includes most of the organisms responsible for the various infectious arthritides in swine, such as staphylococci, streptococci, Erysipelothrix and Mycoplasma spp. It is also indicated for the treatment of mycoplasma pneumonia.
Contraindications:
As with all drugs, the use of Lincomycin Injection is contraindicated in animals previously found to be hypersensitive to the drug.
Adverse reactions:
The intramuscular administration to swine may cause a transient diarrhea or loose stools. Although this effect has rarely been reported, one must be alert to the possibility that it may occur. Should this occur, it is important that the necessary steps be taken to prevent the effects of dehydration.
Dosage and Administration:
For arthritis or mycoplasma pneumonia–7.5mg/lb body weight intramuscularly once daily for three to seven days as needed.
For optimal results, initiate treatment as soon as possible. As with any multi-dose vial, practice aseptic techniques in withdrawing each dose. Adequately clean and disinfect the vial closure prior to entry with a sterile needle and syringe. No vial closure should be entered more than 20 times.
Packing:
Vial of 100 ml.
Warning:
Swine intended for human consumption should not be slaughtered within 48 hours of latest treatment.
Keep out of reach of children.
Use for animals only.
